SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
6.61
+0.92 (16.08%)
Aug 4, 2026, 2:29 PM EDT - Market open

SOPHiA GENETICS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-80.3-77.49-61.27-78.5-87.59-73.51
Depreciation & Amortization
10.529.538.68.345.573.61
Stock-Based Compensation
15.8216.2116.4915.2413.618.51
Other Adjustments
5.115.35-5.211.62-1.42-2.35
Change in Receivables
-4.72-6.65.89-6.51.331.81
Changes in Inventories
-1.440.050.07-0.87-0.2-2.34
Changes in Accounts Payable
15.3416.93-7.396.87-1.438.98
Changes in Other Operating Activities
-0.08-1.9805.220.02-2.66
Operating Cash Flow
-39.64-35.69-43.98-52.42-71.09-57.94
Operating Cash Flow Growth
------
Capital Expenditures
-1.47-0.57-0.24-1.49-4.1-2.68
Purchases of Intangible Assets
-9.25-8.05-7.93-7.73-6.28-3.99
Purchases of Investments
--1.89---26.18-72.14
Proceeds from Sale of Investments
---17.5578.5321.88
Investing Cash Flow
-11.13-8.67-4.7612.9841.97-56.93
Long-Term Debt Issued
-34.5613.93---
Long-Term Debt Repaid
------3.17
Net Long-Term Debt Issued (Repaid)
-34.5613.93---3.17
Issuance of Common Stock
18.221.440.410.230.75244.33
Net Common Stock Issued (Repurchased)
18.221.440.410.230.75244.33
Other Financing Activities
-2.18-1.87-2.75-3.04-2.32-3.39
Financing Cash Flow
64.6630.189.86-2.82-1.57237.77
Foreign Exchange Rate Adjustments
-0.954.45-3.615.02-1.97-4.56
Net Cash Flow
13.79-14.39-39.41-43.07-29.69122.9
Free Cash Flow
-41.11-36.27-44.22-53.92-75.19-60.62
Free Cash Flow Growth
------
FCF Margin
-47.70%-46.93%-67.85%-86.45%-158.09%-149.87%
Free Cash Flow Per Share
-0.59-0.54-0.67-0.83-1.17-1.10
Levered Free Cash Flow
-58-20.49-47.53-60.92-87.58-71.93
Unlevered Free Cash Flow
-51.37-48.34-66.86-57.23-87.82-66.74
SEC Filings: 10-K · 10-Q